SC 13D

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Filing Date
Dec 1, 2021
Document Date
Dec 1, 2021
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
Other
Company
KemPharm
Issuer
KEMPHARM, INC